Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers

Materials Science and Engineering C

Volumn 67, Issue , 2016, Pages 611-622

  Zhao, Linlin ^a,b   Kim, Tae Hyun ^c,d   Kim, Hae Won ^c,d   Ahn, Jin Chul ^c   Kim, So Yeon ^b  

^a TIANJIN UNIVERSITY OF TECHNOLOGY   (China)

^b Chungnam National University   (South Korea)

^c Dankook University   (South Korea)

^d BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

Author keywords

Gold nanoparticles; Imaging; Photodynamic therapy; Theranostics; Verteporfin

Indexed keywords

BLOCK COPOLYMERS; DIAGNOSIS; DISEASE CONTROL; DISEASES; FIBER OPTIC SENSORS; GOLD; HYDROPHOBICITY; IMAGING TECHNIQUES; LIGHT SCATTERING; METAL NANOPARTICLES; NANOPARTICLES; OPTICAL PROPERTIES; PHOTOSENSITIZERS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

CONJUGATED BLOCK COPOLYMERS; GOLD NANOPARTICLES; INTRACELLULAR UPTAKE; LIGHT SCATTERING MEASUREMENT; MULTI-FUNCTIONAL NANOCARRIERS; THERANOSTIC NANOCARRIERS; THERANOSTICS; VERTEPORFIN;

PHOTODYNAMIC THERAPY;

DRUG CARRIER; GOLD; METAL NANOPARTICLE; PORPHYRIN; VERTEPORFIN;

CHEMISTRY; DIAGNOSTIC IMAGING; HELA CELL LINE; HUMAN; METABOLISM; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES; THERANOSTIC NANOMEDICINE;

DRUG CARRIERS; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PORPHYRINS; THERANOSTIC NANOMEDICINE;

EID: 84971350774     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.05.047     Document Type: Article

References (59)

1. J. Funkhouser Reintroducing pharma: theranostic revolution Curr. Drug Discov. 2 2002 17
2. S.S. Kelkar, and T.M. Reineke Theranostics: combining imaging and therapy Bioconjug. Chem. 22 2011 1879 1903
3. B. Sumer, and J.M. Gao Theranostic nanomedicine for cancer Nanomedicine 3 2008 137 140
4. J.R. McCarthy The future of theranostic nanoagents Nanomedicine 4 2009 693 695
5. P. Kumar, and R. Srivastava IR 820 stabilized multifunctional polycaprolactone glycol chitosan composite nanoparticles for cancer therapy RSC Adv. 5 2015 56162 56170
6. M. Zhang, Y. Cao, Y. Chong, Y. Ma, H. Zhang, Z. Deng, C. Hu, and Z. Zhang Graphene oxide based theranostic platform for T1 weighted magnetic resonance imaging and drug delivery ACS Appl. Mater. Interfaces 5 2013 13325 13332
7. M. Thakur, S. Pandey, A. Mewada, V. Patil, M. Khade, E. Goshi, and M. Sharon Antibiotic conjugated fluorescent carbon dots as a theranostic agent for controlled drug release J. Drug Deliv. 2014 2014 282193 282201
8. R. Ackroyd, C. Kelty, N. Brown, and M. Reed The history of photodetection and photodynamic therapy Photochem. Photobiol. 74 2001 656 669
9. T.J. Dougherty, C.J. Gomer, and B.W. Henderson Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
10. B.C. Wilson Photodynamic therapy for cancer: principles Can. J. Gastroenterol. 16 2002 393 396
11. T.J. Dougherty Photosensitizers: therapy and detection of malignant tumors Photochem. Photobiol. 45 1987 879 889
12. R.R. Allison, R.E. Cuenca, G.H. Downie, P. Camnitz, B. Brodish, and C.H. Sibata Clinical photodynamic therapy of head and neck cancers-a review of applications and outcomes Photodiagn. Photodyn. Ther. 2 2005 205 222
13. M.C. DeRosa, and R.J. Crutchley Photosensitized singlet oxygen and its applications Coord. Chem. Rev. 233-234 2002 351 371
14. Y.N. Konan, R. Gurny, and E. Allemann State of the art in the delivery of photosensitizers for photodynamic therapy J. Photochem. Photobiol. B 66 2002 89 106
15. S. Ferro, F. Ricchelli, G. Mancini, G. Tognon, and G. Jori Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents J. Photochem. Photobiol. B 83 2006 98 104
16. Y. Bae, N. Nishiyama, and K. Kataoka In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments Bioconjug. Chem. 18 2007 1131 1139
17. G.D. Zhang, A. Harada, N. Nishiyama, D.L. Jiang, H. Koyama, T. Aida, and K. Kataoka Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer J. Control. Release 93 2003 141 150
18. Q. Zhang, X. Wang, P.Z. Li, T.N. Kim, X.J. Wang, Z. Luo, H. Zhang, N.S. Tan, and Y. Zhao Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer-targeted drug delivery in vivo Adv. Funct. Mater. 24 2014 2450 2461
19. 4 nanoparticles: towards high performance MRI contrast agents Adv. Mater. 26 2014 2694 2698
20. D.C. Hone, P.I. Walker, R.E. Gowing, S. FitzGerald, A. Beeby, I. Chambrier, M.J. Cook, and D.A. Russell Generation of cytotoxic singlet oxygen via phthalocyanine-stabilized gold nanoparticles: a potential delivery vehicle for photodynamic therapy Langmuir 18 2002 2985 2987
21. B. Kim, G. Han, B.J. Toley, C.K. Kim, V.M. Rotello, and N.S. Forbes Tuning payload delivery in tumour cylindroids using gold nanoparticles Nat. Nanotechnol. 5 2010 465 472
22. P.D. Howes, S. Rana, and M.M. Stevens Plasmonic nanomaterials for biodiagnostics Chem. Soc. Rev. 43 2014 3835 3853
23. N. Nishiyama, Y. Bae, K. Miyata, S. Fukushima, and K. Kataoka Smart polymeric micelles for gene and drug delivery Drug Discov. Today: Technol. 2 2005 21 26
24. S. Mura, J. Nicolas, and P. Couvreur Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
25. J. Li, X. Yu, Y. Wang, Y. Yuan, H. Xiao, D. Cheng, and X. Shuai A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery Adv. Mater. 26 2014 8217 8224
26. Z. Ge, and S. Liu Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance Chem. Soc. Rev. 42 2013 7289 7325
27. Q. Yin, J. Shen, Z. Zhang, H. Yu, and Y. Li Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor Adv. Drug Deliv. Rev. 65 2013 1699 1715
28. K.R. West, and S. Otto Reversible covalent chemistry in drug delivery Curr. Drug Discov. Technol. 2 2005 123 160
29. L. Zhao, T.H. Kim, K.M. Huh, H.W. Kim, and S.Y. Kim Self-assembled photosensitizer-conjugated nanoparticles for targeted photodynamic therapy J. Biomater. Appl. 28 2013 434 447
30. Y. Cheng, A.C. Samia, J. Li, M.E. Kenney, A. Resnick, and C. Burda Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface Langmuir 26 2010 2248 2255
31. Y. Cheng, A.C. Samia, J.D. Meyers, I. Panagopoulos, B. Fei, and C. Burda Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer J. Am. Chem. Soc. 130 2008 10643 10647
32. T. Stuchinskaya, M. Moreno, M.J. Cook, D.R. Edwardsb, and D.A. Russell Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates Photochem. Photobiol. Sci. 10 2011 822 831
33. L. Zhao, T.H. Kim, J.C. Ahn, H.W. Kim, and S.Y. Kim Highly efficient "theranostics" system based on surface-modified gold nanocarriers for imaging and photodynamic therapy of cancer J. Mater. Chem. B 1 2013 5806 5817
34. N.M. Bressler Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group Arch. Ophthalmol. 117 1999 1329 1345
35. R.Z. Renno, Y. Terada, M.J. Haddadin, N.A. Michaud, E.S. Gragoudas, and J.W. Miller Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2 Arch. Ophthalmol. 122 2004 1002 1011
36. U.S. Erfurth, and S. Sacu Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration Ophthalmology 115 2008 134 140
37. M. Prabaharan, J.J. Grailer, S. Pilla, D.A. Steeber, and S.Q. Gong Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery Biomaterials 30 2009 5757 5766
38. M. Yokoyama, G.S. Kwon, T. Okano, Y. Sakurai, T. Seto, and K. Kataoka Preparation of micelle-forming polymer-drug conjugates Bioconjug. Chem. 3 1992 295 301
39. K. Akamatsu, Y. Yamasaki, M. Nishikawa, Y. Takakura, and M. Hashida Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice J. Pharmacol. Exp. Ther. 290 1999 1242 1249
40. B.C. Mei, K. Susumu1, I.L. Medintz, and H. Mattoussil Polyethylene glycol-based bidentate ligands to enhance quantum dot and gold nanoparticle stability in biological media Nat. Protoc. 4 2009 412 423
41. G. Frens Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions Nature 241 1973 20 22
42. W. Haiss, N.T.K. Thanh, J. Aveyard, and D.G. Fernig Determination of size and concentration of gold nanoparticles from UV-Vis spectra Anal. Chem. 79 2007 4215 4221
43. E. Oh, K. Susumu, J.B.B. Canosa, I.L. Medintz, P.E. Dawson, and H. Mattoussi Preparation of stable maleimide-functionalized au nanoparticles and their use in counting surface ligands Small 6 2010 1273 1278
44. K. Knop, A.-F. Mingotaud, N. El-Akra, F. Violleau, and J.-P. Souchard Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-ϵ-caprolactone) micelles for photodynamic therapy Photochem. Photobiol. Sci. 8 2009 394 404
45. H. Ding, B.D. Sumer, C.W. Kessinger, Y. Dong, G. Huang, D.A. Boothman, and J. Gao Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX J. Control. Release 151 2011 271 277
46. B. Bae, and K. Na Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy Biomaterials 31 2010 6325 6335
47. D. Wu, X.D. Zhang, P.X. Liu, L.A. Zhang, F.Y. Fan, and M.L. Guo Gold nanostructure: fabrication, surface modification, targeting imaging, and enhanced radiotherapy Curr. Nanosci. 7 2011 110 118
48. Z. Hassannejad, and M.E. Khosroshahi Synthesis and evaluation of time dependent optical properties of plasmonic-magnetic nanoparticles Opt. Mater. 35 2013 644 651
49. E.C. Dreaden, A.M. Alkilany, X. Huang, C.J. Murphy, and M.A. El-Sayed The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 41 2012 2740 2779
50. K. Nawalany, A. Rusin, M. Kepczynski, A. Mikhailov, G.K. Marek, M. Snietura, J. Poltowicz, Z. Krawczyk, and M. Nowakowska Comparison of photodynamic efficacy of tetraarylporphyrin pegylated or encapsulated in liposomes: in vitro studies J. Photochem. Photobiol. B 97 2009 8 17
51. Y.L. Liu, M.K. Shipton, J. Ryan, E.D. Kaufman, S. Franzen, and D.L. Feldheim Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers Anal. Chem. 79 2007 2221 2229
52. P. Nativo, I.A. Prior, and M. Brust Uptake and intracellular fate of surface-modified gold nanoparticles ACS Nano 2 2008 1639 1644
53. I. Canton, and G. Battaglia Endocytosis at the nanoscale Chem. Soc. Rev. 41 2012 2718 2739
54. S. Mukherjee, R.N. Ghosh, and F.R. Maxfield Endocytosis Physiol. Rev. 77 1997 759 803
55. C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, E.C. Goldsmith, and S.C. Baxter Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41 2008 1721 1730
56. N. Lewinski, V. Colvin, and R. Drezek Cytotoxicity of nanoparticles Small 4 2008 26 49
57. E. Boisselier, and D. Astruc Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity Chem. Soc. Rev. 38 2009 1759 1782
58. P. Ghosh, G. Han, M. De, C.K. Kim, and V.M. Rotello Gold nanoparticles in delivery applications Adv. Drug Deliv. Rev. 60 2008 1307 1315
59. K.E. Schmalenberg, L. Frauchiger, L.N. Albers, and K.E. Uhrich Cytotoxicity of a unimolecular polymeric micelle and its degradation products Biomacromolecules 2 2001 851 855